Results
76,342 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Duquesne Family Office LLC13F filer |  AAAlcoa CorpTRIM | SELL | $68K 1.31M sh | Aug 14, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Duquesne Family Office LLC13F filer | AAAlcoa Corp TRIM | SELL | $68K 1.31M sh | Aug 14, 2026 |
| 16 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $446K 16.1K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 16 | Weaver JesseChief Financial Officer |  HLLYHolley Inc.Tax withholding | F | $103K 32.5K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 16 | Keough JosephDirector |  TILEINTERFACE INCGift | G | — 8,442 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 16 | Richard Dean McCormickSelf |  BLKBlackRock, Inc.Sale | SELL | $1,001 – $15K | Aug 14, 2026 traded Jul 30, 2026 |
| 16 | Ramani HiteshChief Accounting Officer |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $419K 25.0K sh | Aug 14, 2026 traded Aug 14, 2026 |
| 16 | Richard Dean McCormickSelf |  ADIANALOG DEVICES INCSale | SELL | $1,001 – $15K | Aug 14, 2026 traded Jul 30, 2026 |
| 16 | Taylor Randy JSee Remarks |  USFDUS Foods Holding Corp.Option exercise | M | $180K 5,199 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 15 | Marchese Anthony G.Director |  TMRCDyTb, LLCDisposition to issuer | D | — 5.17M sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Marchese Anthony G.Director | TMRCDyTb, LLC Disposition to issuer | D | — 2.02M sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer |  WRBYWarby Parker Inc.Option exercise | M | $766K 200.0K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 15 | Mathers William CCFO | TMRCDyTb, LLC Disposition to issuer | D | — 448.5K sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Rottmann Scott GlennPresident |  RGPRESOURCES CONNECTION, INC.Tax withholding | F | $20K 4,739 sh | Aug 14, 2026 traded Aug 10, 2026 |
| 15 | Wall Cecil CDirector | TMRCDyTb, LLC Disposition to issuer | D | — 1.70M sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Hulse Donald EdwardDirector | TMRCDyTb, LLC Disposition to issuer | D | — 176.6K sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Wall Cecil CDirector | TMRCDyTb, LLC Disposition to issuer | D | — 47.1K sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Beigle Jonathan ScottDirector | TMRCDyTb, LLC Disposition to issuer | D | — 60.8K sh | Aug 14, 2026 traded Aug 7, 2026 |
| 15 | Malhotra DeepakDirector | TMRCDyTb, LLC Disposition to issuer | D | — 244.8K sh | Aug 14, 2026 traded Aug 7, 2026 |
| 14 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $350K 1,568 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $684K 3,080 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 14 | Blake SarahSVP, Chief Accounting Officer |  VGVenture Global, Inc.Option exercise | M | $1.55M 1.00M sh | Aug 14, 2026 traded Aug 14, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $379K 1,698 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $582K 2,595 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $407K 1,800 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 14 | Jergensen JoshuaPresident & COO |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $161K 3,625 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $623K 2,765 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $651K 2,943 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Brodie Bradley HarrisSVP, General Counsel,Secretary |  DOUGDouglas Elliman Inc.Tax withholding | F | $49K 24.6K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 13 | Lin Shao-LeeDirector, Chief Executive Officer |  CUECue Biopharma, Inc.Option exercise | M | — 109.2K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $30K 4,000 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 13 | Mancini Christopher AndrewSVP OF PROF SALES & STORE OPS |  ORLYO REILLY AUTOMOTIVE INCOption exercise | M | — 3,000 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $38K 5,000 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Ravella SatishChief Accounting Officer |  ZETAZeta Global Holdings Corp.Option exercise | M | — 6,250 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Rubin JonathanSVP, Chief Medical Officer |  SUPNSUPERNUS PHARMACEUTICALS, INC.Option exercise | M | — 750 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Russell Alan JDirector, Chief Scientific Officer |  EWTXEdgewise Therapeutics, Inc.Option exercise | M | — 7,031 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Option exercise | M | — 1,650 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Russell Alan JDirector, Chief Scientific Officer | EWTXEdgewise Therapeutics, Inc. Option exercise | M | — 7,031 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Russell Alan JDirector, Chief Scientific Officer | EWTXEdgewise Therapeutics, Inc. Option exercise | M | — 5,781 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 13 | Veness Adam MSVP, General Counsel and Sec. |  DNTHDianthus Therapeutics, Inc. /DE/Option exercise | M | — 15.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 13 | Kim John C.Director |  OWLTOwlet, Inc.Grant or award | A | — 26.8K sh | Aug 14, 2026 traded Aug 12, 2026 |